Akili Inc Quick Ratio (AKLI) starting from the first quarter 2024 to first quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Akili Inc   (NASDAQ: AKLI)

Akili Inc 's Quick Ratio

AKLI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2024, Quick Ratio deteriorated to 6.05 below Akili Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Quick Ratio than Akili Inc in first quarter 2024. While Quick Ratio total ranking has improved so far during the Q1 2024 to 517, from total ranking in the fourth quarter 2023 at 536.

Explain Quick Ratio?
How much Cash & cash equivalents AKLI´s has?
What are AKLI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKLI Quick Ratio (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1
Y / Y Current Liabilities Change -1.68 % -4.44 % -6.58 % 59.42 % 84.6 %
Y / Y Cash & cash equivalent Change -46.22 % -44.8 % -44.82 % 72872.34 % 167693 %
Quick Ratio MRQ 6.05 6.15 7.03 8.56 11.07
AKLI's Total Ranking # 517 # 536 # 424 # 291 # 289
Seq. Current Liabilities Change -14.56 % -0.52 % -0.69 % 16.48 % -16.96 %
Seq. Cash & cash equivalent Change -15.95 % -12.9 % -18.48 % -9.88 % -13.73 %



Quick Ratio first quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 280
Overall Market # 517


Quick Ratio Statistics
High Average Low
11.9 6.09 0.01
(Sep 30 2022)   (Mar 31 2022)




Financial Statements
Akili Inc 's Current Liabilities $ 10 Millions Visit AKLI's Balance sheet
Akili Inc 's Cash & cash equivalent $ 63 Millions Visit AKLI's Balance sheet
Source of AKLI's Sales Visit AKLI's Sales by Geography


Cumulative Akili Inc 's Quick Ratio

AKLI's Quick Ratio for the trailling 12 Months

AKLI Quick Ratio

 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 6.77 % 20.39 % 31.76 % 109.32 % 177.99 %
Y / Y Cash & cash equivalent TTM Growth -19.42 % 31.43 % 90.9 % 564.36 % 427.68 %
Quick Ratio TTM 6.99 8.11 9.28 10.55 9.26
Total Ranking TTM # 3239 # 3165 # 3241 # 3059 # 221
Seq. Current Liabilities TTM Growth -0.38 % -1.18 % -1.77 % 10.4 % 12.34 %
Seq. Cash & cash equivalent TTM Growth -14.11 % -13.68 % -13.59 % 25.78 % 40.1 %

Quick ratio ranking by company, industry and sector >> Back to AKLI Financial Strength Comparisons >> Go to Compare AKLI Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in AKLI's Current Liabilities to $10.43 millions, cumulative Quick Ratio to 6.99 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Akili Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 3165 to 3239.

Explain Quick Ratio?
How much Cash & cash equivalents AKLI´s has?
What are AKLI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 939
Within the Market # 3239


trailing twelve months Quick Ratio Statistics
High Average Low
10.05 5.51 0.07
(Jun 30 2023)   (Jun 30 2022)




Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Medical Equipment & Supplies Industry Quick RatioMar 31 2024 MRQ Cash & cash equivalentMar 31 2024 MRQ Current Liabilities
Soleno Therapeutics Inc  13.91 $ 149.627  Millions$ 10.759  Millions
Semler Scientific inc   12.79 $ 62.754  Millions$ 4.907  Millions
Perspective Therapeutics Inc   12.46 $ 180.648  Millions$ 14.503  Millions
Pulse Biosciences Inc   12.40 $ 34.885  Millions$ 2.813  Millions
Retractable Technologies Inc  12.29 $ 46.642  Millions$ 3.796  Millions
Vicarious Surgical Inc  12.10 $ 73.230  Millions$ 6.050  Millions
Heartbeam Inc   11.52 $ 12.638  Millions$ 1.097  Millions
Inmode Ltd   11.23 $ 596.472  Millions$ 53.096  Millions
Shockwave Medical Inc   11.15 $ 1,029.233  Millions$ 92.334  Millions
Autonomix Medical Inc   11.08 $ 8.608  Millions$ 0.777  Millions
Sight Sciences Inc   10.89 $ 127.284  Millions$ 11.693  Millions
Novocure Limited  10.32 $ 870.147  Millions$ 84.316  Millions
Femasys Inc   10.08 $ 17.836  Millions$ 1.769  Millions
Inspire Medical Systems inc   9.77 $ 441.361  Millions$ 45.190  Millions
Nevro Corp   9.61 $ 281.483  Millions$ 29.292  Millions
Cvrx inc   9.54 $ 80.115  Millions$ 8.398  Millions
Neurometrix Inc   9.53 $ 17.599  Millions$ 1.847  Millions
Co diagnostics Inc   9.48 $ 49.964  Millions$ 5.270  Millions
Fractyl Health Inc   9.15 $ 121.441  Millions$ 13.272  Millions
Orasure Technologies Inc  9.06 $ 263.772  Millions$ 29.105  Millions
Alpha Pro Tech Ltd   8.96 $ 18.510  Millions$ 2.065  Millions
Modular Medical Inc  8.53 $ 9.232  Millions$ 1.082  Millions
Silk Road Medical Inc   8.18 $ 174.462  Millions$ 21.337  Millions
Orchestra Biomed Holdings Inc   7.54 $ 75.038  Millions$ 9.951  Millions
Irhythm Holdings Inc   7.25 $ 569.092  Millions$ 78.484  Millions
Hyperfine Inc   7.21 $ 63.204  Millions$ 8.767  Millions
Transmedics Group Inc   6.97 $ 350.217  Millions$ 50.223  Millions
Inspiremd Inc   6.96 $ 33.950  Millions$ 4.877  Millions
Axonics Inc   6.88 $ 332.806  Millions$ 48.387  Millions
Rxsight Inc   6.84 $ 125.354  Millions$ 18.328  Millions

Date modified: 2026-09-08T15:11:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.